ARVN

SEC source: 0001655759-24-000085 · wk-form4_1717192358.xml · nonDerivative · entry 1

Kennedy Edward Moore Jr. · CIK 0001753859 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,405

F1 · shares: The restricted stock units (each, an "RSU") were granted by the Issuer on May 29, 2024 and each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement for no consideration. The RSUs shall vest in full on the earlier of May 29, 2025 or the first meeting of the board of directors of the Issuer held after the following annual meeting of stockholders.

SEC source: 0001655759-24-000081 · wk-form4_1717192234.xml · derivative · entry 2

Norwalk Leslie V · CIK 0001533568 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,070

Underlying: Common Stock · 9,070 shares

Expires 2034-05-28

F2 · derivative.exercise_date: This option award was granted on May 29, 2024. The shares underlying the award shall vest in full on the earlier of May 29, 2025 or the first meeting of the board of directors of the Issuer held after the following annual meeting of stockholders.

SEC source: 0001655759-24-000081 · wk-form4_1717192234.xml · nonDerivative · entry 1

Norwalk Leslie V · CIK 0001533568 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,020

F1 · shares: The restricted stock units (each, an "RSU") were granted by the Issuer on May 29, 2024 and each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement for no consideration. The RSUs shall vest in full on the earlier of May 29, 2025 or the first meeting of the board of directors of the Issuer held after the following annual meeting of stockholders.

SEC source: 0001655759-24-000082 · wk-form4_1717192266.xml · derivative · entry 2

YOUNG JOHN D · CIK 0001551792 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,070

Underlying: Common Stock · 9,070 shares

Expires 2034-05-28

F2 · derivative.exercise_date: This option award was granted on May 29, 2024. The shares underlying the award shall vest in full on the earlier of May 29, 2025 or the first meeting of the board of directors of the Issuer held after the following annual meeting of stockholders.

SEC source: 0001655759-24-000082 · wk-form4_1717192266.xml · nonDerivative · entry 1

YOUNG JOHN D · CIK 0001551792 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,020

F1 · shares: The restricted stock units (each, an "RSU") were granted by the Issuer on May 29, 2024 and each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement for no consideration. The RSUs shall vest in full on the earlier of May 29, 2025 or the first meeting of the board of directors of the Issuer held after the following annual meeting of stockholders.

SEC source: 0001655759-24-000087 · wk-form4_1717192424.xml · derivative · entry 2

Cunningham Everett · CIK 0001564777 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,070

Underlying: Common Stock · 9,070 shares

Expires 2034-05-28

F2 · derivative.exercise_date: This option award was granted on May 29, 2024. The shares underlying the award shall vest in full on the earlier of May 29, 2025 or the first meeting of the board of directors of the Issuer held after the following annual meeting of stockholders.

SEC source: 0001655759-24-000087 · wk-form4_1717192424.xml · nonDerivative · entry 1

Cunningham Everett · CIK 0001564777 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,020

F1 · shares: The restricted stock units (each, an "RSU") were granted by the Issuer on May 29, 2024 and each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement for no consideration. The RSUs shall vest in full on the earlier of May 29, 2025 or the first meeting of the board of directors of the Issuer held after the following annual meeting of stockholders.

SEC source: 0001655759-24-000089 · wk-form4_1717192478.xml · derivative · entry 2

Bain Linda · CIK 0001578407 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,070

Underlying: Common Stock · 9,070 shares

Expires 2034-05-28

F2 · derivative.exercise_date: This option award was granted on May 29, 2024. The shares underlying the award shall vest in full on the earlier of May 29, 2025 or the first meeting of the board of directors of the Issuer held after the following annual meeting of stockholders.

SEC source: 0001655759-24-000089 · wk-form4_1717192478.xml · nonDerivative · entry 1

Bain Linda · CIK 0001578407 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,020

F1 · shares: The restricted stock units (each, an "RSU") were granted by the Issuer on May 29, 2024 and each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement for no consideration. The RSUs shall vest in full on the earlier of May 29, 2025 or the first meeting of the board of directors of the Issuer held after the following annual meeting of stockholders.

SEC source: 0001655759-24-000080 · wk-form4_1717192202.xml · derivative · entry 2

Smaldone Alsup Laurie · CIK 0001589602 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,070

Underlying: Common Stock · 9,070 shares

Expires 2034-05-28

F2 · derivative.exercise_date: This option award was granted on May 29, 2024. The shares underlying the award shall vest in full on the earlier of May 29, 2025 or the first meeting of the board of directors of the Issuer held after the following annual meeting of stockholders.

SEC source: 0001655759-24-000080 · wk-form4_1717192202.xml · nonDerivative · entry 1

Smaldone Alsup Laurie · CIK 0001589602 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,020

F1 · shares: The restricted stock units (each, an "RSU") were granted by the Issuer on May 29, 2024 and each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement for no consideration. The RSUs shall vest in full on the earlier of May 29, 2025 or the first meeting of the board of directors of the Issuer held after the following annual meeting of stockholders.

SEC source: 0001655759-24-000084 · wk-form4_1717192326.xml · derivative · entry 2

AGARWAL SUNIL · CIK 0001616640 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,070

Underlying: Common Stock · 9,070 shares

Expires 2034-05-28

F2 · derivative.exercise_date: This option award was granted on May 29, 2024. The shares underlying the award shall vest in full on the earlier of May 29, 2025 or the first meeting of the board of directors of the Issuer held after the following annual meeting of stockholders.

SEC source: 0001655759-24-000084 · wk-form4_1717192326.xml · nonDerivative · entry 1

AGARWAL SUNIL · CIK 0001616640 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,141

F1 · shares: The restricted stock units (each, an "RSU") were granted by the Issuer on May 29, 2024 and each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement for no consideration. The RSUs shall vest in full on the earlier of May 29, 2025 or the first meeting of the board of directors of the Issuer held after the following annual meeting of stockholders.

SEC source: 0001655759-24-000083 · wk-form4_1717192298.xml · derivative · entry 2

Morrison Briggs · CIK 0001654430 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,070

Underlying: Common Stock · 9,070 shares

Expires 2034-05-28

F2 · derivative.exercise_date: This option award was granted on May 29, 2024. The shares underlying the award shall vest in full on the earlier of May 29, 2025 or the first meeting of the board of directors of the Issuer held after the following annual meeting of stockholders.

SEC source: 0001655759-24-000083 · wk-form4_1717192298.xml · nonDerivative · entry 1

Morrison Briggs · CIK 0001654430 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,996

F1 · shares: The restricted stock units (each, an "RSU") were granted by the Issuer on May 29, 2024 and each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement for no consideration. The RSUs shall vest in full on the earlier of May 29, 2025 or the first meeting of the board of directors of the Issuer held after the following annual meeting of stockholders.

SEC source: 0001655759-24-000065 · wk-form4_1716515270.xml · derivative · entry 2

Teel Randy · CIK 0002015998 · Int. Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,675

Underlying: Common Stock · 19,675 shares

Expires 2034-05-20

F2 · derivative.exercise_date: The option was granted by the Issuer on May 21, 2024, in connection with the reporting person being named as Chief Business Officer of the Issuer, pursuant to the Plan. The shares underlying the option will vest over two years: 1/2 of the shares underlying the award shall vest on April 21, 2025, with the remainder of the shares vesting on April 21, 2026.

SEC source: 0001655759-24-000065 · wk-form4_1716515270.xml · nonDerivative · entry 1

Teel Randy · CIK 0002015998 · Int. Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 59,341

F1 · shares: The restricted stock units (each, an "RSU") were granted by the issuer on May 21, 2024, in connection with the reporting person being named as Chief Business Officer of the Issuer, pursuant to its 2018 Stock Incentive Plan (the "Plan") and each RSU represents a contingent right to receive one share of the issuer's common stock upon settlement for no consideration. The RSUs will vest over two years: 1/2 of the shares underlying the award shall vest on April 21, 2025, with the remainder of the shares vesting on April 21, 2026.

SEC source: 0001655759-24-000040 · wk-form4_1711052087.xml · derivative · entry 2

Berkowitz Noah · CIK 0001369900 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 93,879

Underlying: Common Stock · 93,879 shares

Expires 2034-03-17

F2 · derivative.exercise_date: The option was granted by the Issuer on March 18, 2024, in accordance with Nasdaq Listing Rule 5635(c)(4) and not pursuant the Plan. The shares underlying the option will vest over four years: 1/4 of the shares underlying the award shall vest on March 18, 2025, with the remainder of the shares vesting in equal monthly installments following March 18, 2025 through March 18, 2028.

SEC source: 0001655759-24-000040 · wk-form4_1711052087.xml · nonDerivative · entry 1

Berkowitz Noah · CIK 0001369900 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 63,452

F1 · shares: The restricted stock units (each, an "RSU") were granted by the Issuer on March 18, 2024, in accordance with Nasdaq Listing Rule 5635(c)(4), and not pursuant to its 2018 Stock Incentive Plan (the "Plan"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement for no consideration. The RSUs will vest over four years: 25% of the RSUs will vest on each of March 18, 2025, March 18, 2026, March 18, 2027 and March 18, 2028, subject to the Reporting Person's continued service with the Issuer on each such vesting date.

SEC source: 0001655759-24-000024 · wk-form4_1709076774.xml · derivative · entry 2

Loomis David K · CIK 0001959410 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,750

Underlying: Common Stock · 8,750 shares

Expires 0034-02-22

F2 · derivative.exercise_date: The option was granted by the Issuer on February 23, 2024, pursuant to the Plan. The shares underlying the option will vest over two years: 1/2 of the shares underlying the award shall vest on February 23, 2025, with the remainder of the shares vesting on February 23, 2026.

SEC source: 0001655759-24-000024 · wk-form4_1709076774.xml · nonDerivative · entry 1

Loomis David K · CIK 0001959410 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,500

F1 · shares: The restricted stock units (each, an "RSU") were granted by the issuer on February 23, 2024, pursuant to its 2018 Stock Incentive Plan (the "Plan") and each RSU represents a contingent right to receive one share of the issuer's common stock upon settlement for no consideration. The RSUs will vest over two years: 1/2 of the shares underlying the award shall vest on February 23, 2025, with the remainder of the shares vesting on February 23, 2026.

SEC source: 0001655759-24-000025 · wk-form4_1709076814.xml · derivative · entry 3

Taylor Ian · CIK 0001753281 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 58,100

Underlying: Common Stock · 58,100 shares

Expires 2034-02-22

F3 · derivative.exercise_date: The option was granted by the Issuer on February 23, 2024, pursuant to the Plan. The shares underlying the option will vest over two years: 1/2 of the shares underlying the award shall vest on February 23, 2025, with the remainder of the shares vesting on February 23, 2026.

SEC source: 0001655759-24-000025 · wk-form4_1709076814.xml · nonDerivative · entry 2

Taylor Ian · CIK 0001753281 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 147,522

F2 · shares: This sale was made to cover withholding taxes following the vesting of previously granted Restricted Stock Units.

SEC source: 0001655759-24-000025 · wk-form4_1709076814.xml · nonDerivative · entry 1

Taylor Ian · CIK 0001753281 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 149,223

F1 · shares: The restricted stock units (each, an "RSU") were granted by the Issuer on February 23, 2024, pursuant to its 2018 Stock Incentive Plan (the "Plan") and each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement for no consideration. The RSUs will vest over two years: 1/2 of the shares underlying the award shall vest on February 23, 2025, with the remainder of the shares vesting in on February 23, 2026.

SEC source: 0001655759-24-000027 · wk-form4_1709076882.xml · nonDerivative · entry 1

Cassidy Sean A · CIK 0001421914 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 181,916

F1 · shares: This sale was made to cover withholding taxes following the vesting of previously granted Restricted Stock Units.

SEC source: 0001655759-24-000028 · wk-form4_1709076907.xml · derivative · entry 3

Houston John G · CIK 0001753537 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 184,200

Underlying: Common Stock · 184,200 shares

Expires 2034-02-22

F3 · derivative.exercise_date: The option was granted by the Issuer on February 23, 2024, pursuant to the Plan. The shares underlying the option will vest over two years: 1/2 of the shares underlying the award shall vest on February 23, 2025, with the remainder of the shares vesting on February 23, 2026.

SEC source: 0001655759-24-000028 · wk-form4_1709076907.xml · nonDerivative · entry 2

Houston John G · CIK 0001753537 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,036,681

F2 · shares: This sale was made to cover withholding taxes following the vesting of previously granted Restricted Stock Units.

SEC source: 0001655759-24-000028 · wk-form4_1709076907.xml · nonDerivative · entry 1

Houston John G · CIK 0001753537 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,041,877

F1 · shares: The restricted stock units (each, an "RSU") were granted by the Issuer on February 23, 2024, pursuant to its 2018 Stock Incentive Plan (the "Plan") and each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement for no consideration. The RSUs will vest over two years: 1/2 of the shares underlying the award shall vest on February 23, 2025, with the remainder of the shares vesting on February 23, 2026.

SEC source: 0001655759-24-000026 · wk-form4_1709076838.xml · derivative · entry 3

Peck Ronald · CIK 0001783868 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 58,100

Underlying: Common Stock · 58,100 shares

Expires 2034-02-22

F3 · derivative.exercise_date: The option was granted by the Issuer on February 23, 2024, pursuant to the Plan. The shares underlying the option will vest over two years: 1/2 of the shares underlying the award shall vest on February 23, 2025, with the remainder of the shares vesting on February 23, 2026.

SEC source: 0001655759-24-000026 · wk-form4_1709076838.xml · nonDerivative · entry 2

Peck Ronald · CIK 0001783868 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 67,516

F2 · shares: This sale was made to cover withholding taxes following the vesting of previously granted Restricted Stock Units.

SEC source: 0001655759-24-000026 · wk-form4_1709076838.xml · nonDerivative · entry 1

Peck Ronald · CIK 0001783868 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 69,215

F1 · shares: The restricted stock units (each, an "RSU") were granted by the Issuer on February 23, 2024, pursuant to its 2018 Stock Incentive Plan (the "Plan") and each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement for no consideration. The RSUs will vest over two years: 1/2 of the shares underlying the award shall vest on February 23, 2025, with the remainder of the shares vesting on February 23, 2026.

SEC source: 0001655759-24-000004 · wk-form4_1704749977.xml · derivative · entry 3

Taylor Ian · CIK 0001753281 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,065

Underlying: Common Stock · 4,899 shares

Expires 2028-09-25

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: This option award was granted on September 26, 2018. 1/4 of the shares underlying the award vested as of March 31, 2019, and the remainder of the shares vested in equal monthly installments following March 31, 2019 through March 31, 2022.

SEC source: 0001655759-24-000004 · wk-form4_1704749977.xml · derivative · entry 2

Taylor Ian · CIK 0001753281 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,519

Underlying: Common Stock · 3,353 shares

Expires 2028-09-25

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: This option award was granted on September 26, 2018. 1/4 of the shares underlying the award vested as of June 28, 2019, and the remainder of the shares vested in equal monthly installments following June 28, 2019 through June 28, 2022.

SEC source: 0001655759-24-000004 · wk-form4_1704749977.xml · nonDerivative · entry 1

Taylor Ian · CIK 0001753281 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 109,973

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001655759-24-000133 · wk-form4_1731450837.xml · nonDerivative · entry 1

Loomis David K · CIK 0001959410 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,271

F1 · shares: This sale was made to cover withholding taxes following the vesting of previously granted Restricted Stock Units.

SEC source: 0001655759-23-000081 · wk-form4_1692048412.xml · derivative · entry 3

Peck Ronald · CIK 0001783868 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 4,010 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock.

F3 · derivative.exercise_date: On July 29, 2019, the reporting person was granted 16,041 Restricted Stock Units, vesting in four equal annual installments beginning July 29, 2020.

F3 · derivative.expiration_date: On July 29, 2019, the reporting person was granted 16,041 Restricted Stock Units, vesting in four equal annual installments beginning July 29, 2020.

SEC source: 0001655759-23-000081 · wk-form4_1692048412.xml · nonDerivative · entry 2

Peck Ronald · CIK 0001783868 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 29,965

F2 · shares: This sale was made to cover withholding taxes following the vesting of previously granted Restricted Stock Units.

SEC source: 0001655759-23-000081 · wk-form4_1692048412.xml · nonDerivative · entry 1

Peck Ronald · CIK 0001783868 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 31,289

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock.

SEC source: 0001655759-23-000064 · wk-form4_1687296436.xml · derivative · entry 3

Kennedy Edward Moore Jr. · CIK 0001753859 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,787

Underlying: Common Stock · 12,787 shares

Expires 2033-06-14

F3 · derivative.exercise_date: This option award was granted on June 15, 2023. The shares underlying the award shall vest in full on the earlier of June 15, 2024 or the first meeting of the board of directors of the Issuer held after the following annual meeting of stockholders.

SEC source: 0001655759-23-000064 · wk-form4_1687296436.xml · nonDerivative · entry 1

Kennedy Edward Moore Jr. · CIK 0001753859 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,506

F1 · shares: The restricted stock units (each, an "RSU") were granted by the Issuer on June 15, 2023 and each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement for no consideration. The RSUs shall vest in full on the earlier of June 15, 2024 or the first meeting of the board of directors of the Issuer held after the following annual meeting of stockholders.

SEC source: 0001655759-23-000063 · wk-form4_1687296408.xml · derivative · entry 2

DIXON WENDY L · CIK 0001202283 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,787

Underlying: Common Stock · 12,787 shares

Expires 2033-06-14

F2 · derivative.exercise_date: This option award was granted on June 15, 2023. The shares underlying the award shall vest in full on the earlier of June 15, 2024 or the first meeting of the board of directors of the Issuer held after the following annual meeting of stockholders.

SEC source: 0001655759-23-000063 · wk-form4_1687296408.xml · nonDerivative · entry 1

DIXON WENDY L · CIK 0001202283 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,121

F1 · shares: The restricted stock units (each, an "RSU") were granted by the Issuer on June 15, 2023 and each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement for no consideration. The RSUs shall vest in full on the earlier of June 15, 2024 or the first meeting of the board of directors of the Issuer held after the following annual meeting of stockholders.

SEC source: 0001655759-23-000066 · wk-form4_1687296490.xml · derivative · entry 2

Norwalk Leslie V · CIK 0001533568 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,787

Underlying: Common Stock · 12,787 shares

Expires 2033-06-14

F2 · derivative.exercise_date: This option award was granted on June 15, 2023. The shares underlying the award shall vest in full on the earlier of June 15, 2024 or the first meeting of the board of directors of the Issuer held after the following annual meeting of stockholders.

SEC source: 0001655759-23-000066 · wk-form4_1687296490.xml · nonDerivative · entry 1

Norwalk Leslie V · CIK 0001533568 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,121

F1 · shares: The restricted stock units (each, an "RSU") were granted by the Issuer on June 15, 2023 and each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement for no consideration. The RSUs shall vest in full on the earlier of June 15, 2024 or the first meeting of the board of directors of the Issuer held after the following annual meeting of stockholders.

SEC source: 0001655759-23-000068 · wk-form4_1687296539.xml · derivative · entry 2

YOUNG JOHN D · CIK 0001551792 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,787

Underlying: Common Stock · 12,787 shares

Expires 2033-06-14

F2 · derivative.exercise_date: This option award was granted on June 15, 2023. The shares underlying the award shall vest in full on the earlier of June 15, 2024 or the first meeting of the board of directors of the Issuer held after the following annual meeting of stockholders.

SEC source: 0001655759-23-000068 · wk-form4_1687296539.xml · nonDerivative · entry 1

YOUNG JOHN D · CIK 0001551792 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,121

F1 · shares: The restricted stock units (each, an "RSU") were granted by the Issuer on June 15, 2023 and each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement for no consideration. The RSUs shall vest in full on the earlier of June 15, 2024 or the first meeting of the board of directors of the Issuer held after the following annual meeting of stockholders.

SEC source: 0001655759-23-000062 · wk-form4_1687296379.xml · derivative · entry 2

Cunningham Everett · CIK 0001564777 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,787

Underlying: Common Stock · 12,787 shares

Expires 2033-06-14

F2 · derivative.exercise_date: This option award was granted on June 15, 2023. The shares underlying the award shall vest in full on the earlier of June 15, 2024 or the first meeting of the board of directors of the Issuer held after the following annual meeting of stockholders.

SEC source: 0001655759-23-000062 · wk-form4_1687296379.xml · nonDerivative · entry 1

Cunningham Everett · CIK 0001564777 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,121

F1 · shares: The restricted stock units (each, an "RSU") were granted by the Issuer on June 15, 2023 and each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement for no consideration. The RSUs shall vest in full on the earlier of June 15, 2024 or the first meeting of the board of directors of the Issuer held after the following annual meeting of stockholders

SEC source: 0001655759-23-000060 · wk-form4_1687296337.xml · derivative · entry 2

Bain Linda · CIK 0001578407 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,787

Underlying: Common Stock · 12,787 shares

Expires 2033-06-14

F2 · derivative.exercise_date: This option award was granted on June 15, 2023. The shares underlying the award shall vest in full on the earlier of June 15, 2024 or the first meeting of the board of directors of the Issuer held after the following annual meeting of stockholders.

SEC source: 0001655759-23-000060 · wk-form4_1687296337.xml · nonDerivative · entry 1

Bain Linda · CIK 0001578407 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,121

F1 · shares: The restricted stock units (each, an "RSU") were granted by the Issuer on June 15, 2023 and each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement for no consideration. The RSUs shall vest in full on the earlier of June 15, 2024 or the first meeting of the board of directors of the Issuer held after the following annual meeting of stockholders.